Oncology / MDS & AML

High-Risk MDS: Investigating Novel Combination Therapies

clinical topic updates by Rami S. Komrokji, MD

An improved understanding of high-risk myelodysplastic syndrome (MDS) has led to clinical trials exploring novel combination treatment strategies. ......READ MORE

LATEST IN Oncology

MDS & AML

Predicting Progression of Lower-Risk MDS

expert roundtables by Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; and Rami S. Komrokji, MD

Our featured experts consider the natural history of lower-risk myelodysplastic syndrome (MDS). Risk stratification increasingly incorporates genom......READ MORE

MDS & AML

Perspectives on Newly Diagnosed MDS

expert roundtables by Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; and Rami S. Komrokji, MD

In the treatment of patients with newly diagnosed myelodysplastic syndrome (MDS), there are opportunities for risk stratification, prognostication,......READ MORE

Browse More Articles